Written by:
Dr. Sophie Reynolds
Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Vilitra 20 mg Tablet
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
![]() | Valif 20 mg Tablet | Ajanta Pharma | ₱ 0.00 |
![]() | Zhewitra 20 mg Jelly | Sunrise Remedies | Ask for Price |
![]() | Levitra 20 mg Tablet | Bayer Zydus Pharma Pvt Ltd | Ask for Price |
Description
What is Vilitra 20 mg Tablet? Vilitra 20 mg is a medicine used in the management of erectile dysfunction (ED) in adult men. Erectile dysfunction is a condition where a man finds it difficult to achieve or maintain an erection during sexual activity. Vilitra 20 mg contains Vardenafil as its active ingredient. Vardenafil belongs to a group of medicines known as phosphodiesterase type 5 (PDE5) inhibitors, which help improve blood flow to the penis during sexual stimulation. Vilitra 20 mg is manufactured by Centurion Laboratories and is available as an oral tablet. Uses of Vilitra 20 mg Tablet Vilitra 20 mg is primarily used for: Erectile dysfunction (ED) Supporting erection quality during sexual activity Men who do not get adequate response from lower-strength ED medicines How Does Vilitra 20 mg Work Vardenafil works by blocking the PDE5 enzyme, which normally reduces blood flow by breaking
Benefits
Vilitra 20 mg offers a range of clinically supported and practically meaningful benefits for men managing erectile dysfunction:
Highly potent and selective: Vardenafil’s high binding affinity for PDE-5 makes it one of the most pharmacologically targeted ED treatments available, producing reliable results with a well-established safety profile.
Fast and predictable onset: Most men experience effects within 25–60 minutes, making it practical for real-world intimacy without excessive advance planning.
Less food-dependent than sildenafil: Vardenafil is significantly less affected by meals than sildenafil, giving men more flexibility around when and what they eat before taking the medication.
Effective in difficult-to-treat populations: Vilitra 20 mg has strong clinical evidence supporting its use in men with diabetes, post-surgical ED, and significant cardiovascular risk factors — populations where some other ED medications may be less reliable.
Restores natural sexual confidence: By providing reliable physical support, Vilitra 20 mg helps break the cycle of performance anxiety, allowing men to be present and connected during intimacy rather than preoccupied with worry.
Comfortable duration of action: Effects lasting 4–6 hours provide a natural window for intimacy without the very prolonged duration of tadalafil, which some men and doctors prefer from a side effect and safety management standpoint.
Trusted active ingredient: Vardenafil has been approved and prescribed globally since 2003, with an extensive body of clinical evidence supporting its efficacy and safety.
Improved relationship quality: Studies on vardenafil consistently demonstrate improvements not just in erectile function scores, but in overall sexual satisfaction, relationship quality, and emotional wellbeing reported by both men and their partners.
Indications and Usage
Vilitra 20 mg is indicated for the treatment of erectile dysfunction in adult men — defined as the persistent or recurrent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
It is intended for use in men aged 18 and above who have been assessed and diagnosed by a qualified healthcare provider. It is not indicated for use in women, adolescents, or children.
Vilitra 20 mg may be appropriate for men with ED arising from:
- Cardiovascular or vascular causes including hypertension and atherosclerosis
- Diabetes mellitus — vardenafil has been specifically studied and shown effective in diabetic men with ED
- Post-radical prostatectomy — vardenafil has demonstrated efficacy in men with nerve-sparing and non-nerve-sparing prostatectomy
- Psychological or psychogenic causes including performance anxiety and stress-related ED
- Mixed aetiology — a combination of physical and psychological contributing factors, which represents the majority of ED cases
Vilitra 20 mg is not indicated for:
- Women or children
- Men who do not have a diagnosis of erectile dysfunction
- Recreational use or enhancement of normal erectile function
- Use alongside nitrate medications or recreational nitrates under any circumstances
How it Works
Vilitra 20 mg works through a well-understood and precisely targeted pharmacological mechanism that supports the body’s natural erectile response.
The Physiology of an Erection
When a man becomes sexually aroused, the nervous system releases nitric oxide into the smooth muscle tissue of the penile blood vessels. Nitric oxide activates an enzyme called guanylate cyclase, which converts guanosine triphosphate (GTP) into cyclic GMP (cGMP). Cyclic GMP causes the smooth muscle cells lining the blood vessels of the penis to relax and dilate, dramatically increasing blood flow into the erectile tissues — the corpora cavernosa — producing an erection.
Under normal conditions, once arousal subsides, another enzyme — phosphodiesterase type 5 (PDE-5) — breaks down cyclic GMP, causing the smooth muscles to contract again and blood to flow out of the penis, ending the erection. This is a healthy, natural regulatory process.
How ED Disrupts This Process
In men with erectile dysfunction, PDE-5 activity is either excessively high, nitric oxide release is insufficient, or the vascular system is compromised by conditions such as atherosclerosis or diabetes. The result is that cyclic GMP is broken down too quickly or is not produced in sufficient quantities — meaning blood flow to the erectile tissues is inadequate and a satisfactory erection cannot be achieved or maintained.
How Vardenafil Restores Function
Vardenafil is a highly selective, competitive inhibitor of PDE-5. By binding to and blocking the PDE-5 enzyme, it prevents the premature breakdown of cyclic GMP during sexual arousal. This allows cyclic GMP to accumulate to levels sufficient to produce meaningful smooth muscle relaxation and sustained blood flow into the erectile tissues — resulting in a firm, reliable erection.
Vardenafil’s particularly high selectivity for PDE-5 over other phosphodiesterase enzymes — including PDE-6, which is involved in retinal function — means it produces its intended effect with a degree of precision that contributes to its favourable tolerability in many men.
Because the entire mechanism is dependent on the initial release of nitric oxide triggered by sexual arousal, Vilitra 20 mg only works in the presence of genuine sexual stimulation. This is an important safety feature — it means the medication works with the body’s natural processes rather than overriding them.
Dosage & Administration
Standard recommended dose: One Vilitra 20 mg tablet taken orally, approximately 25–60 minutes before anticipated sexual activity.
Maximum frequency: No more than one tablet within any 24-hour period.
How to take it:
- Swallow the tablet whole with a full glass of water
- Can be taken with or without food — vardenafil is less sensitive to food than sildenafil, though very high-fat meals may still slightly delay absorption
- Do not crush, break, or chew the tablet
- Avoid grapefruit and grapefruit juice around the time of taking
Onset and duration:
- Effects typically begin within 25–60 minutes of taking
- Duration of effect is approximately 4–6 hours
- Individual response times vary — some men notice effects sooner, others may take slightly longer
Starting dose considerations:
- Men new to vardenafil, older adults, or those with liver or kidney impairment are often started on the 10 mg dose
- The 20 mg dose is appropriate for men with moderate to severe ED or those who have not achieved sufficient results with a lower dose
- Always follow your doctor’s dosing recommendation
Missed dose: Since Vilitra 20 mg is taken on an as-needed basis, a missed dose is not applicable in the usual sense. Simply take it when you plan to engage in sexual activity, and never take more than one dose in 24 hours.
Overdose warning: Taking more than the prescribed dose does not improve results and significantly increases the risk of serious adverse effects including severe hypotension, prolonged erections, and cardiac events. If an overdose is suspected, seek emergency medical attention immediately.
Side Effects
Vilitra 20 mg is generally well tolerated, but like all medications it can cause side effects in some men. Being informed about what to watch for allows you to respond appropriately.
Common side effects (mild and usually temporary):
- Headache — the most frequently reported side effect, typically mild and resolving within a few hours
- Facial flushing — warmth or redness in the face, neck, or chest reflecting the medication’s vasodilatory effects
- Nasal congestion — mild stuffiness due to dilation of nasal blood vessels
- Indigestion or dyspepsia — usually mild; taking with a light meal may help
- Dizziness or light-headedness — particularly when standing up quickly; move slowly and stay hydrated
- Back pain or muscle aches — may appear 12–24 hours after taking and usually resolves without treatment
Less common side effects (inform your doctor if these occur):
- Temporary visual disturbances — blurred vision or mild changes in colour perception
- Skin flushing or warmth beyond the face
- Palpitations or increased awareness of heartbeat
- Mild nausea
Serious side effects (seek immediate medical attention):
- Priapism — a painful, prolonged erection lasting more than 4 hours. This is a medical emergency requiring immediate treatment to prevent permanent damage to erectile tissue. Do not wait to see if it resolves on its own
- Sudden loss of vision in one or both eyes — stop the medication immediately and seek emergency care. A rare condition called non-arteritic anterior ischaemic optic neuropathy (NAION) has been reported with PDE-5 inhibitors
- Sudden loss of hearing, sometimes with tinnitus or dizziness — requires urgent medical attention
- Severe allergic reaction — facial or throat swelling, hives, difficulty breathing, or chest tightness
- Chest pain, pressure, or pain radiating to the jaw or arm — particularly concerning in men with cardiovascular risk factors; treat as a cardiac emergency
If you experience any symptom that concerns you after taking Vilitra 20 mg, contact your healthcare provider or pharmacist promptly. When in doubt, always err on the side of caution.
Warning and Precaution
Do not take Vilitra 20 mg if you:
- Take nitrate medications for chest pain or heart conditions in any form — oral, sublingual, patch, or spray (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate). The combination causes a dangerous, potentially life-threatening drop in blood pressure
- Use recreational nitrate-based drugs (“poppers”) — the same serious interaction applies
- Have been advised by your doctor to avoid sexual activity due to cardiovascular risk
- Have had a heart attack, stroke, or life-threatening arrhythmia within the past 6 months
- Have severe liver impairment (Child-Pugh Class C)
- Have end-stage renal disease requiring dialysis
- Take potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, or indinavir at maximum doses — these significantly increase vardenafil blood levels
- Have a history of NAION (non-arteritic anterior ischaemic optic neuropathy)
- Are allergic to vardenafil or any excipient in the tablet
- Have rare hereditary conditions such as galactose intolerance
Use with caution and inform your doctor if you:
- Take alpha-blockers for blood pressure or prostate conditions — a dose separation of at least 6 hours is recommended and dose adjustment may be needed
- Have unstable angina, uncontrolled hypertension, or poorly controlled blood pressure
- Have a physical deformity of the penis such as Peyronie’s disease
- Have conditions predisposing to priapism — sickle cell anaemia, multiple myeloma, or leukaemia
- Have retinitis pigmentosa — a rare inherited retinal condition
- Have a prolonged QT interval on ECG or are taking medications that affect heart rhythm
- Have moderate liver impairment — a lower starting dose is recommended
Lifestyle considerations:
- Alcohol: Combining alcohol with vardenafil increases the risk of dizziness, low blood pressure, and flushing. Limit alcohol intake when taking Vilitra 20 mg
- Grapefruit juice: Can increase vardenafil blood levels unpredictably — avoid around the time of dosing
- Driving and machinery: If you experience dizziness or visual disturbances, do not drive or operate heavy machinery
Patient Guidance
Starting treatment for erectile dysfunction is a positive and proactive step. Here is straightforward, practical guidance to help you use Vilitra 20 mg safely and effectively:
See a doctor before you start. ED is sometimes the earliest warning sign of cardiovascular disease, diabetes, or hormonal imbalance. A proper medical assessment ensures you receive the right treatment and that any underlying conditions are identified and managed.
Share your complete medical history. Vardenafil interacts with several medications — particularly nitrates and alpha-blockers — in ways that can be medically serious. Your doctor and pharmacist need a full picture of everything you take, including supplements and herbal products.
Take it at the right time. Vilitra 20 mg works best when taken 30–60 minutes before sexual activity, ideally after a light meal or on an empty stomach. Very fatty meals can slow absorption slightly, though vardenafil is considerably less food-sensitive than sildenafil.
Limit alcohol. Alcohol and vardenafil both lower blood pressure. Combining them — particularly in larger amounts — increases the risk of dizziness, flushing, and light-headedness, and can also independently impair erection quality.
Create the right conditions. Vardenafil requires sexual stimulation to work. A relaxed environment, genuine intimacy, and freedom from distraction make a real difference to how well the medication performs. It supports your body’s natural response — it cannot manufacture arousal where none exists.
Be patient with the process. Some men find Vilitra 20 mg works perfectly on the first attempt. Others find it takes a few tries to find the optimal timing and conditions. Both experiences are normal. Do not increase your dose without medical guidance if results are initially inconsistent.
Address the bigger picture. Lifestyle factors — smoking, excessive alcohol, lack of exercise, poor sleep, unmanaged stress — all contribute to ED. Medication works most effectively as part of a broader commitment to health. If psychological factors are playing a significant role, psychosexual therapy or counselling alongside medication can produce significantly better long-term outcomes.
Store the medication correctly. Keep at room temperature, away from moisture, heat, and direct sunlight, in original packaging, and out of reach of children.
Never share your medication. Even if someone describes identical symptoms, this medication is prescribed based on individual health factors. What is safe and appropriate for you may not be safe for someone else.
Follow up with your doctor. If side effects occur, if the medication is not working as expected, or if your health circumstances change, speak to your doctor. Adjustments to dose or medication type can almost always be made — but they should always be medically guided.
Clinical Trial & Approvals
Vardenafil — the active ingredient in Vilitra 20 mg — has a robust and well-documented clinical evidence base accumulated over more than two decades.
Vardenafil received approval from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) in 2003 for the treatment of erectile dysfunction in adult men. It has since been approved in numerous countries worldwide and has been the subject of hundreds of clinical studies involving tens of thousands of men.
Key highlights from the clinical evidence:
- Large-scale randomised, double-blind, placebo-controlled trials consistently demonstrated that vardenafil produced statistically and clinically significant improvements in erectile function scores, rates of successful intercourse, and patient-reported satisfaction compared to placebo
- Studies in men with diabetic ED — one of the hardest-to-treat ED populations — showed that vardenafil produced meaningful improvements in erectile function even in this challenging group, where vascular and neurological damage often reduces response to treatment
- Clinical trials in men following radical prostatectomy demonstrated efficacy in both nerve-sparing and non-nerve-sparing procedures, supporting vardenafil’s role in post-surgical rehabilitation of erectile function
- Studies comparing vardenafil to sildenafil suggested comparable or superior efficacy in certain populations, with some men who did not respond adequately to sildenafil achieving satisfactory results with vardenafil
- Long-term open-label studies confirmed sustained efficacy and tolerability with continued use, with no evidence of tachyphylaxis (tolerance development) over time
- Cardiovascular safety studies confirmed that vardenafil does not adversely affect heart rate or blood pressure in men with stable cardiovascular disease when used as directed and without nitrates
Vilitra 20 mg by Centurion Laboratories contains vardenafil at the same therapeutically established dose as the reference branded product.
References
- FDA — Vardenafil (Levitra) Approval Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021389s016lbl.pdf
- EMA — Levitra (Vardenafil) Product Information: https://www.ema.europa.eu/en/medicines/human/EPAR/levitra
- MedlinePlus — Vardenafil: https://medlineplus.gov/druginfo/meds/a603035.html
- Mayo Clinic — Vardenafil (Oral Route): https://www.mayoclinic.org/drugs-supplements/vardenafil-oral-route/description/drg-20066594
- NCBI StatPearls — Vardenafil: https://www.ncbi.nlm.nih.gov/books/NBK549843/
- PubMed — Vardenafil in Diabetic ED: https://pubmed.ncbi.nlm.nih.gov/15316029/
- PubMed — Vardenafil Phase III Trial: https://pubmed.ncbi.nlm.nih.gov/12152112/
FAQ
Related Products
Related Posts:
New Hope for Advanced Prostate Cancer: Enzalutamide and Radium-223 Combination Shows Survival Benefit
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 5, 2026.n n Advances in prostate cancer
READ MORE »Colonoscopy: A Comprehensive Guide to Procedure, Preparation, and Prevention
Colonoscopy remains one of the most effective diagnostic and preventive procedures in modern medicine, playing a critical role in the
READ MORE »
